Literature DB >> 15782111

G-protein-activated phospholipase C-beta, new partners for cell polarity proteins Par3 and Par6.

Yi Cai1, Lewis J Stafford, Brad A Bryan, Dianne Mitchell, Mingyao Liu.   

Abstract

Cell polarity and asymmetric cell division are fundamental traits of all living cells and play an essential role in embryonic development, neuronal cell chirality formation, and maintenance of mammalian epithelial cell morphology. Heterotrimeric GTP-binding proteins (G proteins) are involved in directing cell polarity and asymmetric cell division in different organisms. However, the mechanism for G-protein-mediated cell polarity and asymmetric cell division is poorly understood. In this study, we have demonstrated that G-protein-activated phospholipase C-beta (PLC-beta) interacts with cell polarity proteins Par3 and Par6 (Par: partition-defective) to form protein complexes and to mediate downstream signal transduction. The interactions between PLC-beta and Par proteins are direct and require the extreme C-terminal-specific sequence motifs of PLC-beta and the PDZ (PSD95/Dlg/ZO-1) domains of Par proteins. Binding of Par proteins with PLC-beta stimulates PLC-beta enzymatic activity, leading to the hydrolysis of phosphatidylinositol-4,5-bisphosphate, and the production of diacylglycerol and inositol 1,4,5-triphosphate, important mediators in cell polarity and cell asymmetric division processes. Furthermore, we have shown that coexpression of PLC-beta with Par proteins induces transcriptional activation coupled to intracellular Ca2+ and the Wnt signaling pathway. Therefore, our data suggest that the interaction of PLC-beta with cell polarity Par proteins may serve as a nexus to transduce extracellular signals to transcriptional regulation through G-protein-mediated signaling pathway in cell polarity and cell asymmetric division.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15782111     DOI: 10.1038/sj.onc.1208593

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

Review 1.  Planar cell polarity in kidney development and disease.

Authors:  Thomas J Carroll; Amrita Das
Journal:  Organogenesis       Date:  2011-07-01       Impact factor: 2.500

Review 2.  Immune regulation by phospholipase C-β isoforms.

Authors:  Wenbin Xiao; Yuko Kawakami; Toshiaki Kawakami
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

Review 3.  Structural insights into phospholipase C-β function.

Authors:  Angeline M Lyon; John J G Tesmer
Journal:  Mol Pharmacol       Date:  2013-07-23       Impact factor: 4.436

Review 4.  The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders.

Authors:  Lili Zhang; Xiangyun Wei
Journal:  J Neurosci       Date:  2022-06-15       Impact factor: 6.709

5.  Distal interactions within the par3-VE-cadherin complex.

Authors:  Robert C Tyler; Francis C Peterson; Brian F Volkman
Journal:  Biochemistry       Date:  2010-02-09       Impact factor: 3.162

6.  PAR6B is required for tight junction formation and activated PKCζ localization in breast cancer.

Authors:  Heather E Cunliffe; Yuan Jiang; Kimberly M Fornace; Fan Yang; Paul S Meltzer
Journal:  Am J Cancer Res       Date:  2012-08-20       Impact factor: 6.166

Review 7.  Par complex in cancer: a regulator of normal cell polarity joins the dark side.

Authors:  V Aranda; M E Nolan; S K Muthuswamy
Journal:  Oncogene       Date:  2008-11-24       Impact factor: 9.867

8.  PAK1IP1, a ribosomal stress-induced nucleolar protein, regulates cell proliferation via the p53-MDM2 loop.

Authors:  Weishi Yu; Zhongwei Qiu; Na Gao; Liren Wang; Hengxiang Cui; Yu Qian; Li Jiang; Jian Luo; Zhengfang Yi; Hua Lu; Dali Li; Mingyao Liu
Journal:  Nucleic Acids Res       Date:  2010-11-21       Impact factor: 16.971

9.  Transcriptome alterations of mitochondrial and coagulation function in schizophrenia by cortical sequencing analysis.

Authors:  Kuo-Chuan Huang; Ko-Chun Yang; Han Lin; Theresa Tsun-Hui Tsao; Sheng-An Lee
Journal:  BMC Genomics       Date:  2014-12-08       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.